CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if giving a dose of heated chemotherapy in the
abdomen immediately after surgery that is done to remove uterine leiomyosarcoma type of
cancer will help lower the risk of the cancer coming back in the future.